NCT00911651View on ClinicalTrials.gov

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

August 31, 2008

Conditions
COPD
Interventions
DRUG

Salbutamol

400 µg inhalation once

DRUG

ipratropium bromide

80 µg inhalation once

Trial Locations (1)

2650

Antwerp University Hospital, Antwerp

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University Hospital, Antwerp

OTHER

NCT00911651 - Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients | Biotech Hunter | Biotech Hunter